Orphengesic Forte Tablet
Product Images NDC 61825-302

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Orphengesic Forte (NDC 61825-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Galt Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Capture1)

Label for ORPHENGESIC FORTE tablets containing orphenadrine citrate 50 mg, aspirin 770 mg, and caffeine 60 mg. The oral tablet package includes 60 tablets and is manufactured by Galt Pharmaceuticals, LLC. The label features the NDC 61825-302-60, barcode, dosage information, and storage instructions.*

FDA Label Image

Orphenadrine (Structure1)

Chemical structure of the active ingredient(s) in ORPHENGESIC FORTE, showing molecular diagrams along with the molecular formula C18H23NO·C6H8O7 and molecular weight 461.51.*

FDA Label Image

Aspirin (Structure2)

Chemical structure of aspirin (acetylsalicylic acid) with its molecular formula C9H8O4 and molecular weight 180.16 depicted.*

FDA Label Image

Caffeine (Structure3)

Chemical structure of caffeine depicted with molecular formula C8H10N4O2 and molecular weight of 194.19.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.